Positives

• A patient who switched from an older S1P modulator described the faster lymphocyte recovery on stopping ponesimod as reassuring, particularly when planning surgery or pregnancy Drugs.com.
  
  
• MS patients on the once-daily oral tablet reported reduced relapse rates and fewer new lesions, with some also noting reduced disability progression MS News Today.
  
  

Negatives

• Users described persistent headache, dizziness, peripheral edema, and back and abdominal pain as the most common bothersome effects WebMD.
  
  
• A patient developed macular edema picked up on routine ophthalmology screening and had to discontinue, despite improvements in her MS lesions PMC.
  
  

Hurdles & Side Effects

• A new starter reported a 14-day titration pack with required first-dose cardiac monitoring because of bradycardia risk, which her clinic could only schedule weeks out WebMD.
  
  
• Patients with post-viral neurological symptoms reported that prescribers were unwilling to use this MS-only approved agent off-label Drugs.com.